Your browser doesn't support javascript.
loading
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.
Creeper, Katherine; Augustson, Bradley; Kusel, Kieran; Fulham, Michael J; Ho, Joy; Quach, Hang; Mollee, Peter; Weber, Nicholas; Talaulikar, Dipti; Johnston, Anna; Murphy, Nick; Joshua, Douglas; Ward, Christopher; Ling, Silvia; Gibson, John; Szer, Jeff; Harrison, Simon; Zannettino, Andrew; Jaksic, Wilfrid; Lee, Cindy; Spencer, Andrew; Kalff, Anna; Szabo, Ferenc; Romeril, Ken; Chan, Henry; Gibbs, Simon; Horvath, Noemi; Prince, H Miles.
Afiliación
  • Creeper K; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Augustson B; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Kusel K; Department of Diagnostic and Interventional Radiology, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Fulham MJ; Department of Molecular Imaging, Royal Prince Alfred Hospital Camperdown, Sydney, New South Wales, Australia.
  • Ho J; Institute of Haematology, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Quach H; Department of Haematology, St Vincent's Hospital and University of Melbourne, Melbourne, Victoria, Australia.
  • Mollee P; Department of Haematology, Princess Alexandra Hospital and University of Queensland, Brisbane, Queensland, Australia.
  • Weber N; Department of Haematology, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
  • Talaulikar D; Department of Haematology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.
  • Johnston A; Department of Clinical Haematology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Murphy N; Department of Clinical Haematology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Joshua D; Institute of Haematology, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Ward C; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Ling S; Department of Haematology, Liverpool Hospital, Sydney, New South Wales, Australia.
  • Gibson J; Institute of Haematology, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Szer J; Department of Clinical Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
  • Harrison S; Department of Clinical Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
  • Zannettino A; Department of Experimental Haematology, University of Adelaide, Adelaide, South Australia, Australia.
  • Jaksic W; Department of Haematology, Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
  • Lee C; Department of Clinical Haematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Spencer A; Department of Clinical Haematology, Alfred Hospital, Melbourne, Victoria, Australia.
  • Kalff A; Department of Clinical Haematology, Alfred Hospital, Melbourne, Victoria, Australia.
  • Szabo F; Department of Haematology, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
  • Romeril K; Bowen Icon Cancer Centre, Wellington, New Zealand.
  • Chan H; Department of Haematology, North Shore Hospital, Auckland, New Zealand.
  • Gibbs S; Department of Clinical Haematology, Monash University Eastern Health Clinical School, Melbourne, Victoria, Australia.
  • Horvath N; Department of Clinical Haematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Prince HM; Department of Clinical Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
Intern Med J ; 51(10): 1707-1712, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34664367
ABSTRACT
Imaging modalities for multiple myeloma (MM) have evolved to enable earlier detection of disease. Furthermore, the diagnosis of MM requiring therapy has recently changed to include disease prior to bone destruction, specifically the detection of focal bone lesions. Focal lesions are early, abnormal areas in the bone marrow, which may signal the development of subsequent lytic lesions that typically occur within the next 18-24 months. Cross-sectional imaging modalities are more sensitive for the detection and monitoring of bone and bone marrow disease and are now included in the International Myeloma Working Group current consensus criteria for initial diagnosis and treatment response assessment. The aim of this consensus practice statement is to review the evidence supporting these modalities. A more detailed Position Statement can be found on the Myeloma Australia website.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraproteinemias / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraproteinemias / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Australia